4c02
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
+ | |||
==Crystal structure of human ACVR1 (ALK2) in complex with FKBP12.6 and dorsomorphin== | ==Crystal structure of human ACVR1 (ALK2) in complex with FKBP12.6 and dorsomorphin== | ||
<StructureSection load='4c02' size='340' side='right' caption='[[4c02]], [[Resolution|resolution]] 2.17Å' scene=''> | <StructureSection load='4c02' size='340' side='right' caption='[[4c02]], [[Resolution|resolution]] 2.17Å' scene=''> | ||
Line 5: | Line 6: | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=FLC:CITRATE+ANION'>FLC</scene>, <scene name='pdbligand=TAK:6-[4-(2-PIPERIDIN-1-YLETHOXY)PHENYL]-3-PYRIDIN-4-YLPYRAZOLO[1,5-A]PYRIMIDINE'>TAK</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=FLC:CITRATE+ANION'>FLC</scene>, <scene name='pdbligand=TAK:6-[4-(2-PIPERIDIN-1-YLETHOXY)PHENYL]-3-PYRIDIN-4-YLPYRAZOLO[1,5-A]PYRIMIDINE'>TAK</scene></td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Peptidylprolyl_isomerase Peptidylprolyl isomerase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=5.2.1.8 5.2.1.8] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Peptidylprolyl_isomerase Peptidylprolyl isomerase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=5.2.1.8 5.2.1.8] </span></td></tr> | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4c02 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4c02 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4c02 RCSB], [http://www.ebi.ac.uk/pdbsum/4c02 PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4c02 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4c02 OCA], [http://pdbe.org/4c02 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4c02 RCSB], [http://www.ebi.ac.uk/pdbsum/4c02 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4c02 ProSAT]</span></td></tr> |
</table> | </table> | ||
== Disease == | == Disease == |
Revision as of 17:01, 2 January 2017
Crystal structure of human ACVR1 (ALK2) in complex with FKBP12.6 and dorsomorphin
|